第七课题组-中草药研发以及功能基因组学的应用

gp-tcm-logo

(English) Probably, given that most CHM were developed in a different medical theoretical system in China, the approved herbal drugs currently used in China will need further R&D before they can be safely used in the EU member states. For pharmaceutical companies in both China and EU Member States developing new herbal medicines, what industrial and legal criteria should be observed so that their products will be approvable in both Continents? WP7 will investigate if functional genomics may provide an additional and efficient component of the approval procedures of CHM for the EU …more

第八届中药全球化联盟年会与首届剑桥中医药论坛

Prof. Hylands at 1st Cambridge TCM Forum sq

8th CGCM Annual Meeting was held on 26th-28th August 2009 in Nottingham …more

WP7 Phase I Kick-off Meeting

Chinese version is not available!